MAGELLAN LONGEVITY
HomeResearchStudy library › NAD metabolism and arterial stiffness after long-term nicotinamide…
Study summary · NAD⁺, sirtuins & cellular energy

Does long-term nicotinamide mononucleotide (NMN) supplementation influence biochemical and metabolic health parameters, including NAD metabolism and arterial stiffness, in healthy middle-aged adults?

In one paragraph

Nicotinamide Mononucleotide, a randomized, double-blind, placebo-controlled trial in 36 healthy middle-aged participants (Sci Rep 2023, PMID 36797393) — NMN supplementation at 250 mg/day was well tolerated with no adverse events. The study noted that while arterial stiffness tended to decrease, no significant difference was found between the two groups, suggesting a potential limitation in statistical power or effect size for this specific outcome.

Source: Sci Rep 2023, PMID 36797393 ↗ · Research map · How Magellan grades evidence · evidence confidence: high

Sci Rep · 2023 · PMID 36797393 · DOI 10.1038/s41598-023-29787-3

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

NMN supplementation safely increased NAD metabolism in healthy middle-aged adults and showed a non-significant trend towards reducing arterial stiffness.

The question

Does long-term nicotinamide mononucleotide (NMN) supplementation influence biochemical and metabolic health parameters, including NAD metabolism and arterial stiffness, in healthy middle-aged adults?

What they tested

The study implicitly hypothesized that NMN supplementation would prevent the reduction of NAD levels and potentially alleviate aging-related diseases, as observed in animal studies.

How they did it

A 12-week randomized, double-blind, placebo-controlled, parallel-group clinical trial was conducted with 36 healthy middle-aged participants. Participants received either 125 mg NMN or placebo twice daily.

What they found

Serum nicotinamide levels were significantly higher in the NMN group compared to the placebo group. Pulse wave velocity, an indicator of arterial stiffness, tended to decrease in the NMN group, but this difference was not statistically significant between the two groups. NMN supplementation at 250 mg/day was well tolerated with no adverse events.

NMN Supplementation Dosage
Values shown: Dose (mg)
NMN Dose per Capsule125
Total Daily NMN Dose250

Participants received 125 mg of NMN per capsule, taken twice daily for a total daily dose of 250 mg.

What it means

NMN supplementation safely and effectively elevated NAD metabolism in healthy middle-aged adults. While NMN showed potential in alleviating arterial stiffness, this effect was not statistically significant in this study.

Limitations

The study noted that while arterial stiffness tended to decrease, no significant difference was found between the two groups, suggesting a potential limitation in statistical power or effect size for this specific outcome.

“NMN supplementation showed potential in alleviating arterial stiffness”— from the published abstract, Sci Rep 2023

The paper at a glance

TitleNAD metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized controlled trial
JournalSci Rep
Year2023
PMID36797393 ↗
DOI10.1038/s41598-023-29787-3 ↗
TopicNAD⁺, sirtuins & cellular energy

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Nicotinamide Mononucleotide (NMN)

In randomized controlled trials, NMN reliably increases blood NAD+ levels and has generally been well tolerated at oral doses up to roughly 900-1250 mg/day, with some trials reporting modest improvements in skeletal-muscle insulin sensitivity, walking speed, aerobic capacity, sleep quality, and diastolic blood…

NAD⁺ Activation Stack (NMN + Resveratrol + Pterostilbene)

Sirtuins require NAD⁺ to deacetylate their targets, so raising NAD⁺ availability and stimulating sirtuin enzymes are complementary strategies. This pairing mirrors the molecular targets engaged by caloric restriction — the most reproducible lifespan-extending intervention in laboratory animals — which is why combined…

Double Wood NMN Capsules

Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide and a direct biosynthetic…

Check price on Amazon ↗

Nutricost NMN Capsules 500mg

Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide and a direct biosynthetic…

Check price on Amazon ↗

NOVOS Boost NMN

Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide and a direct biosynthetic…

Check price on Amazon ↗

NMN Complex 1000 mg (Micro Ingredients)

Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide and a direct biosynthetic…

Check price on Amazon ↗

Purovitalis Liposomal β-NMN

Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide and a direct biosynthetic…

Check price on Amazon ↗

DaVinci Labs NAD+ ACTIVATE

Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide and a direct biosynthetic…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Does long-term nicotinamide mononucleotide (NMN) supplementation influence biochemical and metabolic health parameters, including NAD metabolism and arterial stiffness, in healthy middle-aged adults? [Plain-English summary of Sci Rep 2023, PMID 36797393, DOI 10.1038/s41598-023-29787-3]. Magellan Longevity. https://magellanlongevity.com/study/x1.html
BibTeX
@misc{magellan_x1, title = {Does long-term nicotinamide mononucleotide (NMN) supplementation influence biochemical and metabolic health parameters, including NAD metabolism and arterial stiffness, in healthy middle-aged adults?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/x1.html}}, note = {Plain-English summary of PubMed PMID 36797393; DOI 10.1038/s41598-023-29787-3; Sci Rep 2023. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/x1.html

Related studies in the Magellan library

All 17 Magellan summaries on nad⁺, sirtuins & cellular energy →

How this summary was made. Every section above restates what the published abstract of PMID 36797393 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.